Drugs like the blood thinner heparin face a long and winding road as they’re transformed from raw ingredients into sophisticated medications. At its best, it’s a global drug market that helps patients in all corners of the world get the medications they need. At worst, it’s a supply chain that’s exceedingly difficult to unravel when those drugs are associated with making people sick.
But just how difficult it is to ensure the safety of a final product made with ingredients coming from abroad was glaringly apparent this week in Washington.
“The current regulatory system is woefully insufficient, a fact that has been proven by the tragedies caused by unsafe heparin,” said Rep. John D. Dingell, D-Mich., in a statement Monday. “It’s clear that [the] FDA does not have the ability to protect the American people from unsafe food and drugs.”
0 responses so far
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.